Michael Siebels

6.9k citations
60 papers · 5.5k · 1 hit paper · h-index 23

Impact in

Papers in

Michael Siebels

57 papers receiving 5.3k citations

Michael Siebels's Hit Papers

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma 2007 · 4.0k citations
4.0k0+6+12Years since publication10002.0k3.0k4.0k

Peers

Michael Siebels
Comparison fields: 5 of 111
  • Pulmonary and Respiratory Medicine 3.0k
  • Cancer Research 1.2k
  • Oncology 1.2k
  • Urology 220
  • Molecular Biology 2.0k
Replace I. Bodrogi with:
I. Bodrogi Hungary
Jae‐Lyun Lee South Korea
Daniel Castellano Spain
Tomasz Demkow Poland
Jens Bedke Germany
Jose Antonio Karam United States
Elizabeth R. Plimack United States
Annick D. Van den Abbeele United States
Gary R. Hudes United States
Neeraj Agarwal United States
Michael Siebels relative to I. Bodrogi Hungary I. Bodrogi's profile →
Citations per field
00.5×1.6×
I. Bodrogi · 1×
Citations per year

Countries citing papers authored by Michael Siebels

Since Specialization
Citations

This map shows the geographic impact of Michael Siebels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Siebels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Siebels more than expected).

Fields of papers citing papers by Michael Siebels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Siebels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Siebels. The network helps show where Michael Siebels may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Siebels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Siebels Line = papers co-authored together Michael Siebels links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Hit paper breakdown →
20074012
2 2005203
3 2004163
4 200299
5 201099
6 201091
7 200583
8 200566
9 200147
10 200345
11 200245
12 200037
13 201032
14 200930
15 200529
16 200629
17 200529
18 200528
19 200127
20 199326

About Michael Siebels

Michael Siebels is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Urology, Immunology and Surgery, having authored 60 papers that have together received 5.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Cancer Immunotherapy and Biomarkers (7 papers), Bladder and Urothelial Cancer Treatments (6 papers), Immunotherapy and Immune Responses (6 papers), Renal and related cancers (6 papers), Cancer Genomics and Diagnostics (4 papers), Immune Cell Function and Interaction (4 papers) and Vasculitis and related conditions (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.0k citations), Cancer Research (1.2k citations), Oncology (1.2k citations), Urology (220 citations) and Molecular Biology (2.0k citations). Michael Siebels has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Sylvie Négrier, Tomasz Demkow, Minghua Shan, Tim G Eisen, Sara M. Freeman, Bernard J. Escudier, Walter Michael Stadler, Cezary A. Szczylik, Christine Chevreau and Ronald M. Bukowski. Their work appears in journals such as World Journal of Urology, British Journal of Urology, The Journal of Urology, Nephrology Dialysis Transplantation and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact